Article Text

PDF
Will vaccination against human papillomavirus prevent eye disease? A review of the evidence
  1. D S Hughes1,
  2. N Powell2,
  3. A N Fiander2
  1. 1
    Department of Ophthalmology, Royal Gwent Hospital, Newport, Wales, UK
  2. 2
    Department Obstetrics and Gynaecology, School of Medicine, Cardiff University, Heath Park, Cardiff, Wales, UK
  1. Mr D Hughes, Department of Ophthalmology, Royal Gwent Hospital, Cardiff Road, Newport NP20 2UB, Wales, UK; david.hughes{at}gwent.wales.nhs.uk

Abstract

The role of human papillomavirus (HPV) infection in eye disease is controversial. However, a recent case illustrates the possible role of HPV in conjunctival squamous carcinoma and the potentially devastating effects of this disease. The development of two vaccines to prevent infection with HPV types most commonly associated with anogenital cancers has led to debate about the pros and cons of a national immunisation programme to prevent cervical cancer. The introduction of such a vaccination programme may have an additional beneficial effect on the occurrence of some head and neck, including ocular, cancers. This review discusses the nature of papillomaviruses, mechanisms of infection and carcinogenesis, the possible role of HPV in eye disease, and finally the likely impact of the new prophylactic vaccines.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Patient consent: Consent has been given for publication of figs 1 and 2.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.